Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial

NCT06084000 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT06084000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06084000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 15, 2023
Completion date
February 15, 2031
Enrollment
2,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

de novo stenosis, drug-coated balloon, drug-eluting stent